RC148

RC148 · RemeGen Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RC148, covering 2025-01-23 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC) [Phase 3]

See pricing